How DOGE Cuts Will Change Women’s Health
What: Politico reports women’s health research is taking a hit under Musk’s DOGE budget, including lost grants for maternal mortality studies and reduced capacity to review women’s health treatments.
Key Line: “Women’s health research is already underfunded, under-researched and under-prioritized… These cuts will limit federal agencies’ abilities to address gaps, including women’s health gaps.”
Source: Politico
Study shows women over 70 who screened regularly were diagnosed earlier and had lower mortality.
Interleukin-6 shows early promise in detecting life-threatening sepsis.
AI can analyze breast artery calcifications in mammograms to assess cardiovascular risk.
Critical care doctors reveal fatal consequences of abortion bans in new interviews.
JAMA editorial calls for uniform lactation training among healthcare workers.
Personal essay critiques the lack of information women receive about hormonal birth control side effects.
New data reveals most U.S. teen girls live under abortion restrictions.
Promising cancer immunotherapy study delayed due to NIH layoffs.
The Wall Street Journal examines why women in their 30s and 40s are opting for facelifts earlier than before.
A class action lawsuit reveals dangerous conditions at one CPC, prompting ultrasound regulations.
A New York clerk blocked a Texas court filing targeting a doctor who provided abortion pills.
Breast pump startup Willow takes over UK-based Elvie’s assets, signaling tough market conditions for women’s health companies.
Study shows women over 70 who screened regularly were diagnosed earlier and had lower mortality.
Women’s health startups raised $2.6B in VC funding last year, but exits remain elusive.
McKinsey examines how AI is poised to revolutionize the beauty industry, from marketing to product development.
The Economist finds abortions have increased in some states *after* bans, thanks to telehealth and shield laws.
Marty Makary faces controversies as the new FDA commissioner.
Researchers call for standardized criteria to assess dangerous placenta conditions.
Tariffs could raise prices and limit access to Korean skincare products loved by U.S. consumers.
A study suggests women with urinary incontinence can opt for non-invasive assessments instead of bladder pressure tests.